# S9912 Combination Chemo in Stage III Ovarian Cancer,

> **NCT00003896** · PHASE2 · COMPLETED · sponsor: **SWOG Cancer Research Network** · enrollment: 68 (actual)

## Conditions studied

- Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cavity Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** liposomal doxorubicin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00003896
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** 2008-02
- **Final completion:** 2008-02
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2013-01-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003896, "S9912 Combination Chemo in Stage III Ovarian Cancer,". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00003896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*